NFE2L2 and obesity due to melanocortin 4 receptor deficiency: Of interest, a novel potential therapeutic approach in metabolic syndrome and obesity proposed the use of hormetic molecules to induce NrF2-mediatedcytoprotection against oxidative stress and inflammation [59,60].